IRIS
CAPALBO, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.983
NA - Nord America 1.650
SA - Sud America 684
EU - Europa 569
AF - Africa 117
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.543
SG - Singapore 1.228
CN - Cina 582
BR - Brasile 486
VN - Vietnam 449
HK - Hong Kong 288
IT - Italia 151
FR - Francia 116
KR - Corea 80
AR - Argentina 78
BD - Bangladesh 69
IN - India 49
FI - Finlandia 45
DE - Germania 44
IQ - Iraq 44
NL - Olanda 42
MX - Messico 41
ZA - Sudafrica 38
GB - Regno Unito 35
EC - Ecuador 32
ID - Indonesia 29
CA - Canada 28
RU - Federazione Russa 28
PK - Pakistan 27
CO - Colombia 24
UZ - Uzbekistan 23
MA - Marocco 20
PL - Polonia 18
TN - Tunisia 17
PY - Paraguay 16
TR - Turchia 16
UA - Ucraina 15
VE - Venezuela 15
CZ - Repubblica Ceca 13
JP - Giappone 13
CL - Cile 12
SE - Svezia 11
MY - Malesia 10
BO - Bolivia 8
DZ - Algeria 8
CR - Costa Rica 7
EG - Egitto 7
ES - Italia 7
ET - Etiopia 7
HN - Honduras 7
PA - Panama 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
BH - Bahrain 6
KE - Kenya 6
SA - Arabia Saudita 6
AL - Albania 5
AZ - Azerbaigian 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
LB - Libano 4
LT - Lituania 4
MD - Moldavia 4
NI - Nicaragua 4
OM - Oman 4
SY - Repubblica araba siriana 4
AO - Angola 3
AU - Australia 3
IL - Israele 3
KZ - Kazakistan 3
RO - Romania 3
RS - Serbia 3
AT - Austria 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
GP - Guadalupe 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
MU - Mauritius 2
SI - Slovenia 2
SN - Senegal 2
SR - Suriname 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
Totale 5.989
Salva come PNG Salva come JPEG
Città #
Singapore 542
San Jose 327
Hong Kong 284
Boardman 214
Beijing 192
Dallas 192
Ashburn 189
Ho Chi Minh City 169
Hefei 137
Council Bluffs 108
Hanoi 80
Seoul 78
Lauterbourg 75
São Paulo 42
Helsinki 37
The Dalles 36
Ogden 34
Los Angeles 30
Santa Clara 30
New York 25
Rome 25
West Jordan 22
Amsterdam 21
Da Nang 20
Haiphong 19
Frankfurt am Main 18
Johannesburg 18
Secaucus 18
Tashkent 18
Orem 16
Baghdad 14
Mexico City 14
Brooklyn 13
Chennai 13
Warsaw 13
Biên Hòa 12
Boston 12
Montreal 12
Shanghai 12
Munich 11
Brno 10
Curitiba 10
Falkenstein 10
Guayaquil 10
Tianjin 10
Tokyo 10
Buenos Aires 9
Chicago 9
Dhaka 9
Hải Dương 9
Medellín 9
Milan 9
Quito 9
Stockholm 9
Asunción 8
Atlanta 8
Belo Horizonte 8
Erbil 8
Ninh Bình 8
Phoenix 8
San Francisco 8
Thái Nguyên 8
Brasília 7
Campinas 7
Guangzhou 7
Porto Alegre 7
Addis Ababa 6
Casablanca 6
Córdoba 6
London 6
Nairobi 6
Naples 6
Nha Trang 6
Quảng Ngãi 6
Rio de Janeiro 6
San José 6
São Bernardo do Campo 6
Thái Bình 6
Tunis 6
Ankara 5
Baku 5
Bogotá 5
Cosenza 5
Duque de Caxias 5
Durban 5
Fortaleza 5
Itajaí 5
Manama 5
Osasco 5
Panama City 5
Ribeirão Preto 5
Toronto 5
Turin 5
Wroclaw 5
Amman 4
Aparecida de Goiânia 4
Buffalo 4
Bến Tre 4
Can Tho 4
Caracas 4
Totale 3.543
Salva come PNG Salva come JPEG
Nome #
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC) 168
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 141
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 136
Sistema stabile di coltura in vitro di cellule precursori granulari cerebellari (GCP), metodo stabile per la coltura in vitro di dette cellule e usi di detto sistema o metodo per la coltura in vitro 135
H-Ras gene takes part to the host immune response to COVID-19 92
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 91
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 89
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer 86
High-throughput microRNA profiling of pediatric high-grade gliomas 86
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software 85
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation 85
Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes 84
A novel BRCA2 splice variant identified in a young woman 83
Bioelectrical Impedance Analysis (BIA) to measure alterations on hydroelectrolytic equilibrium of peripheral cells in COVID-19 patients with nonthyroidal illness syndrome (NTIS) 83
BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors 82
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 82
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP 82
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 82
microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1 82
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma 81
Cancer secretome and inflammation: The bright and the dark sides of NF-κB 81
A case of long surviving metastatic retroperitoneal epithelioid sarcoma in a 20 year old male 80
CT based radiomic approach on first line pembrolizumab in lung cancer 80
Beyond BRCA1 and BRCA2: deleterious variants in DNA repair pathway genes in italian families with breast/ovarian and pancreatic cancers 79
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models 78
PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress 78
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report 77
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 76
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 75
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants 74
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 74
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma 74
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer. A novel mechanism of intrinsic drug resistance 74
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 73
The impact of searching for BRCA1/2 large genomic rearrangement on BRCAPRO carrier prediction 73
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain 73
Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview 73
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors 72
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study 72
Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy 72
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families 71
HER2-positive male breast cancer: an update 70
Weekly Paclitaxel-carboplatin As Front-line Chemotherapy In Elderly Patients With Locally Advanced/metastatic (stage Iiib-iv) Non-small-cell Lung Cancer. A Phase Ii Study 69
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest 69
P.04.4 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH SURVIVAL OF PATIENTS WITH PANCREATIC CANCER 68
Gynecological and reproductive factors and the risk of pancreatic cancer. a case-control study 68
Male breast cancer 67
Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer 66
No evidence of sars-cov-2 circulation in rome (Italy) during the pre-pandemic period. Results of a retrospective surveillance 66
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14 65
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis 64
Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond 64
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 62
Severe acute respiratory infections (SARI) surveillance in over-65-years-old patients: the experience of a University hospital (seasons 2017-2018 and 2018-2019) 62
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 62
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 60
Unique pineal gland metastasis of clear cell renal carcinoma: case report and review of the literature 60
Immunohistochemical expression of Dicer in melanoma 60
Does the search for large genomic Rearrangements impact BRCAPRO carrier prediction? 60
Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma 59
Identification of families selected for breast cancer predisposition risk and showing low rate of BRCA1/BRCA2 mutations (< 10%) 59
Diagnostic delay does not influence survival of pancreatic cancer patients 59
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 59
Opposite effect of thyroid hormones on oxidative stress and on mitochondrial respiration in COVID-19 patients 57
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium 57
Phenformin inhibits hedgehog-dependent tumor growth through a complex i-independent redox/corepressor module 57
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 57
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 56
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance 56
The role of peroxiredoxins in cancer 56
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms 56
Predictive biomarkers for checkpoint inhibitor-based immunotherapy: The Galectin-3 signature in NSCLCs 56
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families 54
Hierarchical convolutional models for automatic pneumonia diagnosis based on X-ray images: new strategies in public health 54
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach 54
Next-generation sequencing: recent applications to the analysis of colorectal cancer 53
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model 52
Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 52
Nonthyroidal illness syndrome. to treat or not to treat? Have we answered the question? A review of metanalyses 52
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients 52
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 51
The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway 50
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy 50
The end of the beginning of personalized medicine 37
HER2-Low Expression in Male Breast Cancer: Results from a Multicenter Series in Italy 36
Alternate actions of CDK4/6 inhibitors beyond cell cycle blockade: unexplored roles in therapy resistance 15
Glioblastoma cancer: comparing the effectiveness of 3D conformal radiation therapy and volumetric modulated radiotherapy an artificial intelligence-based survival prediction 14
The Thermal Ablation with MRgFUS: From Physics to Oncological Applications 6
Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells 5
Totale 6.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024340 0 0 0 0 0 0 0 98 58 46 10 128
2024/20251.528 86 181 13 42 77 99 82 52 222 91 140 443
2025/20264.239 546 310 399 355 693 260 556 208 279 326 123 184
Totale 6.107